Gene · 4016
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma. | Int J Med Sci | 2026 | 41799774 | PubTator, text mining | PubMed |
| Tannic Acid Achieves Rapid Scar-Free Corneal Healing by Chelating Excess Copper to Suppress Aberrant LOX-Mediated Fibrosis. | Invest Ophthalmol Vis Sci | 2026 | 41789844 | PubTator, text mining | PubMed |
| The extracellular matrix in inflammation and cancer. | Mol Biomed | 2026 | 41787034 | PubTator, text mining | PubMed |
| Left-Right Determination Factor 2 (LEFTY2) Is an Aqueous Humor Biomarker for Exfoliation Glaucoma. | Transl Vis Sci Technol | 2026 | 41773776 | PubTator, text mining | PubMed |
| RNA-Seq of Gingival Fibroblasts Grown on Collagen Membranes and Hyaluronic Acid. | J Funct Biomater | 2026 | 41745519 | PubTator, text mining | PubMed |
| Adventitial Fibrosis and Fibroblast Mechanosensitivity Are Shaped by Sex and Hormonal Status in Pulmonary Arterial Hypertension. | Cells | 2026 | 41744797 | PubTator, text mining | PubMed |
| Temporal Transcriptomics Leads From Discovery to in Vivo Validation: COL4A3/COL4A6/ COL4A5 and ITGA8 as Novel Arthrofibrosis Biomarkers in Post-traumatic Joint Contracture. | Dose Response | 2026 | 41743075 | PubTator, text mining | PubMed |
| Partial-EMT in oral squamous cell carcinoma: molecular circuitry and clinical translation. | Int J Oral Sci | 2026 | 41611665 | PubTator, text mining | PubMed |
| Burden of Pseudoexfoliation and Pigmentary Glaucoma among American Indian or Alaska Native Patients. | Ophthalmol Sci | 2026 | 41567572 | PubTator, text mining | PubMed |
| The role of metformin in extracellular matrix-based three-dimensional cell culture Models: A mini-review on therapeutic potentials. | Biochem Biophys Rep | 2026 | 41561225 | PubTator, text mining | PubMed |
| Liganded LolCDE structures reveal a common substrate-LolE interaction guiding bacterial lipoprotein transport. | Proc Natl Acad Sci U S A | 2026 | 41557797 | PubTator, text mining | PubMed |
| Features of the spatial organization and qualitative composition of the collagen matrix in prostate cancer. | J Mol Histol | 2026 | 41553564 | PubTator, text mining | PubMed |
| Comparative proteomic analysis of the ECM composition of the human omentum and mesentery, the main sites of ovarian cancer metastasis. | iScience | 2026 | 41550748 | PubTator, text mining | PubMed |
| Advances in molecular genetics and multi-omics of exfoliation syndrome. | Exp Eye Res | 2026 | 41548831 | PubTator, text mining | PubMed |
| The role of the LOX family in cancer. | Eur J Cell Biol | 2026 | 41496180 | PubTator, text mining | PubMed |
| Cuproptosis-Related genes as potential core targets for the Diagnosis, Therapy, and prognosis of glioblastoma. | Funct Integr Genomics | 2026 | 41483059 | PubTator, text mining | PubMed |
| FGF-23 facilitates osteosarcoma metastasis by modulating the miR-4463/LOXL2 axis expression via the ERK, p38, and JNK signaling pathway. | Int J Med Sci | 2026 | 41399365 | PubTator, text mining | PubMed |
| Sildenafil suppresses the activation of hypertrophic scar fibroblasts by promoting the KLF15-mediated inhibition of LOXL1 transcription. | Korean J Physiol Pharmacol | 2026 | 41276898 | PubTator, text mining | PubMed |
| Glioblastoma Prognosis and Therapeutic Response Predicted by a Cancer-Associated Fibroblasts Risk Score. | Mediators Inflamm | 2025 | 41498024 | PubTator, text mining | PubMed |
| Decoding dental mesenchymal stem cells diversity: single-cell transcriptomics maps heterogeneity in molar development. | Front Cell Dev Biol | 2025 | 41445584 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4016/papers?page=2